{
    "2019-03-12": [
        [
            {
                "time": "2019-03-13",
                "original_text": "北上资金重回净买入！杠杆资金持续加仓，他们最爱这些股（附名单）",
                "features": {
                    "keywords": [
                        "北上资金",
                        "净买入",
                        "杠杆资金",
                        "加仓"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "信号！连续4天净卖出结束，北上资金恢复净买入！这些公司重获加仓",
                "features": {
                    "keywords": [
                        "北上资金",
                        "净卖出",
                        "净买入",
                        "加仓"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "公告精选：中国平安上海家化年报出炉；华宝股份大手笔分红",
                "features": {
                    "keywords": [
                        "中国平安",
                        "上海家化",
                        "年报",
                        "分红"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融",
                        "消费品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "恒瑞医药胃癌药通过仿制药一致性评价 15品种已过评",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "胃癌药",
                        "仿制药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "中国生物制药(1177.HK)：研发管线储备丰富引领公司成长，维持“增持”评级，目标价8.14港元",
                "features": {
                    "keywords": [
                        "中国生物制药",
                        "研发管线",
                        "增长",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "医疗保健：首家医药公司正式申请拟科创板上市 荐15股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "科创板",
                        "上市",
                        "推荐股票"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "深度|| 中国生物制药：带量采购落地释放悲观预期，研发管线储备丰富引领公司成长【天风医药】",
                "features": {
                    "keywords": [
                        "中国生物制药",
                        "带量采购",
                        "悲观预期",
                        "研发管线"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "医药周报2019第10期: 首家医药公司正式申请拟科创板上市, 制度创新带动产业升级",
                "features": {
                    "keywords": [
                        "医药周报",
                        "科创板",
                        "制度创新",
                        "产业升级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}